Summary
- Current Price
- As of today, ABVX price is $118.95, up +3.62% on
- Current Price All-Time High
- ABVX price is currently -20.08% below its historical high of $148.83 set on
- Market Cap
- ABVX current market cap is $10B, up +83.21% over the past 365 days
- Revenue
- ABVX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ABVX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | ABIVAX Société Anonyme |
| Ticker | NASDAQ: ABVX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | abivax.com |
| Employees | 69 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $118.95 | |
| Price, 1D Change | +3.62% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.93 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$5.46 | |
| EPS, 1Y Change | -80.43% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$5.46 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $118.95 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$3.71 | - | |
| - | -$3.02 | - | |
| - | -$5.46 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +33.28% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +83.21% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -80.43% | |
| EPS, 3Y | -63.17% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $118.95 | |
| SMA 200 | $119.43 | |
| SMA 50 | $125.58 | |
| EMA 200 | $110.45 | |
| EMA 50 | $119.77 | |
| MACD | -$2.56 | |
| Beta | 0.93 | |
| ATR | $4.56 | |
| 14-Day RSI | 50.68 | |
| 10-Day Volatility | 32.77% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$5.46 | |
| Gross Profit | -$1.21M | |
| Gross Margin | - | |
| Operating Income | -$282.85M | |
| Operating Margin | - | |
| Net Income | -$379.32M | |
| Net Margin | - | |
| EBITDA | -$281.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.07 | |
| 8.75 | ||
| 8.75 | ||
| - | ||
| - | ||
| 38.93 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 20.97 | ||
| -32.78 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $534.62M | |
| $622.91M | ||
| $686.28M | ||
| $647.41M | ||
| $151.66M | ||
| $74.02M | ||
| Total Debt | $37.69M | |
| $1.53M | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $379.32M | ||
| $281.64M | ||
| $1.21M | ||
| $0.00 | ||
| $1.21M | ||
| $0.00 | ||
| $3.15M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$182.93M | ||
| -$15.49M | ||
| $625.00M | ||
| Capex | $160.30K | |
| -$183.09M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| Truist Securities | → | |
| Citizens | → | |
| Wedbush | → | |
| Leerink Partners | → | |
| Jefferies | → | |
| BTIG | → | |
| BTIG | → | |
| Wedbush | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ABVX
FAQ
- What is the ticker symbol for ABIVAX Société Anonyme?
- The ticker symbol for ABIVAX Société Anonyme is NASDAQ:ABVX
- Does ABIVAX Société Anonyme pay dividends?
- No, ABIVAX Société Anonyme does not pay dividends
- What sector is ABIVAX Société Anonyme in?
- ABIVAX Société Anonyme is in the Healthcare sector
- What industry is ABIVAX Société Anonyme in?
- ABIVAX Société Anonyme is in the Biotechnology industry
- What country is ABIVAX Société Anonyme based in?
- ABIVAX Société Anonyme is headquartered in France
- When did ABIVAX Société Anonyme go public?
- ABIVAX Société Anonyme initial public offering (IPO) was on October 20, 2023
- Is ABIVAX Société Anonyme in the S&P 500?
- No, ABIVAX Société Anonyme is not included in the S&P 500 index
- Is ABIVAX Société Anonyme in the NASDAQ 100?
- No, ABIVAX Société Anonyme is not included in the NASDAQ 100 index
- Is ABIVAX Société Anonyme in the Dow Jones?
- No, ABIVAX Société Anonyme is not included in the Dow Jones index
- When was ABIVAX Société Anonyme last earnings report?
- ABIVAX Société Anonyme's most recent earnings report was on August 11, 2025
- When does ABIVAX Société Anonyme report earnings?
- The date for ABIVAX Société Anonyme's next earnings report has not been announced yet
Data Sources & References
- ABVX Official Website www.abivax.com
- ABVX Profile on Yahoo Finance finance.yahoo.com/quote/ABVX
- ABVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abvx